Timed Release Tablet Prednisone in Polymyalgia Rheumatica

clinical trial

Wikidata entity: Q64694610



Quantities

P4135maximum age85
P2899minimum age50
P1132number of participants12

P6099 clinical trial phase ... Q42824827 (phase III clinical trial) phase III clinical trial
P6099 clinical trial phase ... Q42824440 (phase II clinical trial) phase II clinical trial
P17 country ... Q145 (United Kingdom) United Kingdom
P582 end time ... 2010-11-01 ???
P31 instance of ... Q30612 (clinical trial) clinical trial
P1050 medical condition ... Q1752891 (polymyalgia rheumatica) polymyalgia rheumatica
P4844 research intervention ... Q11426176 (prednisolone) prednisolone
P4844 research intervention ... Q27108063 (prednisolone acetate) prednisolone acetate
P4844 research intervention ... Q27262132 (methylprednisolone hemisuccinate) methylprednisolone hemisuccinate
P4844 research intervention ... Q27266327 (prednisolone 21-phosphate) prednisolone 21-phosphate
P4844 research intervention ... Q417222 (methylprednisolone) methylprednisolone
P4844 research intervention ... Q424972 (prednisone) prednisone
P580 start time ... 2009-10-01 ???
P8363 study type ... Q78089383 (interventional study) interventional study
P1476 title Monolingualtext Circadian Variation in Cytokines and the Effect of Timed Release Tablet Prednisone in Polymyalgia Rheumatica ???

External Ids
P3098ClinicalTrials.gov IDNCT00836810

Why not click here or view trends?

log id: 4447956